Skip to Content

DA-033 20 (Abilify MyCite 20 mg)

Generic Name: aripiprazole

Pill with imprint DA-033 20 is White, Round and has been identified as Abilify MyCite 20 mg. It is supplied by Otsuka Pharmaceutical Co., Ltd.

Abilify MyCite is used in the treatment of bipolar disorder; depression; schizophrenia and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Abilify MyCite 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for DA-033 20

Abilify MyCite

Generic Name:
aripiprazole
Imprint:
DA-033 20
Strength:
20 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Atypical antipsychotics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Otsuka Pharmaceutical Co., Ltd
National Drug Code (NDC):
59148-0033

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide